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Abstract 
We investigated the efficacy of fish oils in Portuguese patients with hypertriglyceridaemia and mixed hyperlipidaemia, and 
the influence of fish consumption on the triglyceride lowering capacity of fish oils. Forty patients participated in this 
double-blind study, consisting of a 4-week dietary or wash-out baseline period after which patients were randomly assigned 
to receive either 12 fish oil capsules (3.6 g/day of omega 3) or similar 12 soya oil capsules per day for a period of 2 months. 
There were no statistically significant changes of total, HDL or LDL-cholesterol, and triglycerides. Nevertheless, 
triglycerides increased 19.9% with soya oil and decreased 27.8% with fish oils. Also, there was an inverse relationship 
(p=-0.352) between fish consumption and fish oils effect on triglycerides, and the triglyceride lowering with fish oils 
increased (from 27.8% to 44.4%), reaching borderline significance, if we excluded patients consuming one or more meals 
with fish per day. Glucose increased 11% (P=O.O047) with fish oils. These findings suggest that the triglyceride lowering 
effect of fish oils is affected by fish consumption, and confirm that fish oils increase blood glucose levels in diabetics and 
non-diabetics. 
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1. Introduction 
Evidence in favour of beneficial effects of dietary 
fish oil on prevention or retardation of atherosclero- 
sis, thought to be related to the high quantities of 
omega-3 polyunsaturated fatty acids found in many 
types of fish, has been obtained from epidemiologi- 
cal studies in man and from experimental studies in 
animals [l]. These fatty acids have been reported to 
*Corresponding author. 
have anti-inflammatory and immunosuppressive ef- 
fects, reduce platelet aggregation and monocyte 
adhesion, increase erythrocyte deformability, im- 
prove fibrinolysis, alter prostaglandin synthesis, 
stimulate endothelium-derived relaxing factor syn- 
thesis, lower blood pressure, plasma triacylglycerol 
and very low density lipoprotein, and even to protect 
against peroxidation [2]. 
In Portugal, contrasting with other industrialized 
western countries, mortality from stroke has a higher 
incidence than that from coronary heart disease 
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(respectively 194/ 100 000 and 79/ 100 000 in 1990). 
This discrepancy may be due to the protection 
conferred against coronary heart disease by the 
favorable Mediterranean diet, Portuguese usually are 
high consumers of fish, olive oil, red wine and 
vegetables, with the high mortality from stroke being 
a consequence of a salt intake above 15 g per person 
per day [3]. Unfortunately, the Portuguese diet is 
being progressively westernized. Bearing in mind the 
characteristics of the Portuguese, we thought that it 
would be interesting to study the effect of supplying 
fish oils to Portuguese hypertriglyceridaemic and 
mixed hyperlipidaemic patients, and to investigate 
whether fish consumption affected the triglyceride 
lowering capacity of fish oils or not. 
2. Materials and methods 
Eligible patients were 18 to 70 years old with 
hypertriglyceridaemia (triglycerides >200 mg/dl) or 
mixed hyperlipidaemia (total cholesterol >200 mg/ 
dl and triglycerides >200 mg/dl). All those with 
hypersensitivity to the drug, serum creatinine >1.5 
mg/dl, liver disease, non-atherosclerotic neurologic 
diseases, insulin-dependent diabetes mellitus, 
myocardial infarction or stroke in the previous 6 
months, heart failure, premenopause, secondary hy- 
percholesterolaemia or more than 96 g of alcohol 
consumption per day were excluded. The study 
protocol conforms to the ethical guidelines of the 
1975 Declaration of Helsinki, was approved by the 
Ethics Committee of the hospital, and all patients 
gave informed written consent. 
This was a double-blind study with 2-month 
therapy. After at least 1 month of diet or washout 
period, all participants were randomly assigned to 
receive either 12 capsules/day (4 caps tid) of fish oil 
(12 g/day, 3.6 g/day of w-3, 60% EPA and 40% 
DHA), supplied by Hebron, Caruaru, Brazil, or of 
soya oil ( 12 g/day), prepared in a Portuguese 
laboratory. Compliance was assessed by pill count. 
A sequential sample of 40 patients coming to the 
Atherosclerosis Out-Patient Clinic of the University 
Hospital of Coimbra was studied. Analysis and 
clinical examinations were performed at weeks (-4), 
(0), (+4) and (+8). At the initial clinical examina- 
tion, besides the search for exclusion criteria, body 
mass index, blood pressure, and fish (average num- 
ber of meals with fish per week), tobacco and alcohol 
consumption were registered. Patients with systolic 
2160 and/or diastolic BP ~95 mmHg or taking 
antihypertensive drugs were considered as hyperten- 
sives. 
Total, HDL and LDL cholesterol, triglycerides and 
apoproteins A-I and BlOO were analyzed (all values 
in mg/dl). Serum total cholesterol and triglycerides 
were determined by enzymatic methods on an auto- 
mated analyzer (Hitachi 737). HDL-C and LDL-C 
were determined on an automated analyzer (Hitachi 
705), the first with a Human GBD mbH kit, after 
precipitating other lipoproteins with phosphotungstic 
acid and magnesium chloride, and the second after 
specific precipitation with a bioMCrieux kit. Apo- 
proteins A-I and BlOO were quantified by rate 
nephelometry (Beckman immunochemistry systems). 
Laboratory safety tests consisted of hematology 
and blood chemistries (glucose (mg/dl), creatinine 
(mg/dl), creatine kinase (CK) (U/l), alanine (ALT) 
and aspartate (AST) aminotransferase (U/l), and 
alkaline phosphatase (U/l). 
Data were evaluated using StatView 5 12+ TM from 
Brainpower Inc. The results are presented as 
meankstandard error of the mean. Statistical signifi- 
cance was assessed with paired t-test (2-tail), and 
with 2-factor ANOVA for repeated measures. Owing 
to being not normally distributed, triglycerides were 
log transformed before statistical analysis. Correla- 
tions were calculated with Spearman Rank Correla- 
tion Coefficient on untransformed data. 
3. Results 
The data presented here are related only to 35 
patients (25 females and 10 males), since 5 (4 males 
and 1 female, 2 during the first 4 weeks and 3 
between the 5th and the 8th week, all with soya oil) 
abandoned the study because of adverse effects that 
they attributed to the drug (one with acute pan- 
creatitis and the others with eructations, nausea, 
sensation of repletion, meteorism and epigastralgias). 
We did not rechallenge these patients with soya oil 
capsules or with the gel of the capsules only, so we 
cannot attribute definitely these side effects to soya 
oil. Minor and transitory side effects were referred 
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Table 1 
Comparison between baseline characteristics of patients complet- 
ing the study 
Fish oil Soya oil 
Patients (no.) 20 15* 
Sex 
Male 17 (85) 8 (53) 
Female 3 (15) 7 (47) 
Age 50622.8 56122.7 
BMI 28.9kO.S 30.620.9 
BP (mmW 
Systolic 150.71t6.4 158.356.6 
Diastolic 87.6k3.2 92.322.4 
Heart rate 67.321.6 66.122.2 
Fish consumption 
No. meals/week 5.020.5 4.7t0.6 
Wine drinkers 12 (60) 4 (27) 
Alcohol (g/day) 46.4k7.5 31.2k6.3 
Smokers 2 (10) 0 (0) 
Hypertension 10 (50) 11 (85) 
NiDDiabetes mellitus 4 (20) 2 (13) 
Results presented as mean?standard error of the mean or No. 
(%I. 
*The data presented here is related only to 15 patients, since 5 
abandoned the study. 
2.16 in soya oil patients and of 3.53 in fish oil 
patients at baseline. The different effect of soya oil 
and fish oils on TG and LDL-C is of borderline 
significance (respectively P=O.O867 and P=O.O872 
between groups, 2-factor epeated measures Anova). 
Sex, body mass index, hypertension, diabetes and 
alcohol consumption did not affect the fish oils effect 
on lipid parameters (Zfactor repeated measures 
ANOVA, and simple regression). 
Table 3 shows the change of laboratory safety 
tests with both oils. There is a significant increase in 
glucose levels both in diabetics and non-diabetics. 
by 6 patients taking fish oils and 1 taking soya oil. 
Ages of patients completing the study ranged from 
30-70 years. Soya oil patients consumed a mean of 
11.4 and fish oils patients 11.5 caps/day. The two 
groups were reasonably matched at baseline (Table 
1). 
In order to study the influence of fish consumption 
on the triglyceride lowering effect of fish oils we 
divided the sample into tertiles according to the 
number of meals with fish consumed per week. 
Table 4 shows these results, clearly demonstrating 
that fish oils have no effect on the triglyceride levels 
of patients consuming fish more than 6 times per 
week. The same evidence is shown in Fig. 1. There 
is an inverse correlation between the number of 
meals with fish per week and the triglyceride lower- 
ing effect of fish oils (p corrected for ties= -0.352, 
P=O.O735, n=19). This correlation was calculated 
for only 19 patients because data of fish consumption 
of one patient was lacking. 
4. Discussion 
Table 2 shows the values of the studied parame- With the present study we aimed at examining 
ters at baseline and after 8 weeks of therapy with both the effect of short term supplementation with 
soya oil and fish oil. We had to log transform w-3 fatty acids on the lipid profile of Portuguese 
triglycerides before statistical analysis because they patients (usually are high consumers of fish, olive 
are not normally distributed, having a skewness of oil, red wine and vegetables) with hyper- 
Table 2 
Effect of soya oil and fish oils on serum lipids and apoproteins 
Soya oil (n= 15) Fish oil (n=20) 
Baseline Week 8 % P Baseline Week 8 % P 
Total cholesterol 291215 305rt16 - - 253215 249212 - - 
Triglycerides* 391?46 469264 7 19.9 - 431%114 311255 ~27.8 - 
HDL-cholesterol 37.423.1 37.123.4 - - 33.622.2 33.5t-1.5 - - 
LDL-cholesterol** 151217 1372 14 L10.0 - 117511 126f9 PI.7 - 
apoA-I 18428.9 151k9.2 L 17.9 O.oool 15928.0 131 k6.5 \ 17.6 0.0001 
apoBlO0 2222 11 217?14 - - 188210 185k9.4 - - 
*P=O.O867 between groups (Zfactor repeated measures Anova). 
**P=O.O872 between groups (2-factor repeated measures Anova). 
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Table 3 
Effect of soya oil and fish oils on biochemical parameters 
Soya oil Fish oil 
Baseline Week 8 % P Baseline Week 8 % P 
Glucose 10024.8 104k6.6 - - 109+11.7 121-t-14.5 rll.O 0.0047 
Glucose - non-insulin-dependent 181+38.9 217242.5 P 19.9 0.035 1 
diabetes mellitus (n =4) 
Glucose - non-diabetics (n = 15) 89.523.0 95.9e4.1 /n 7.2 0.0218 
Uric acid 4.9120.53 5.53t0.44 L11.3 - 5.41 AO.33 5.3220.33 - - 
ALT 34.2k6.0 38.428.8 ‘x 12.3 - 27.524.8 29.323.3 - 
AST 25.6t3.3 22.9k2.4 - - 22.522.1 24.Ok2.1 - - 
Alkaline phosphatase 78.8t3.4 85.425.0 - - 68.5T5.2 66.526.1 - - 
Creatinine 0.9220.03 0.95t0.04 - - 1.00~0.04 1.02ZO.04 - - 
Creatine kinase 94k10.5 87k10.7 - 121212.4 135216.7 ~11.6 - 
Evolution of the studied safety parameters with soya oil and fish oils. As glucose increased in the fish oils group, diabetic (all type 2) and 
non-diabetic patients were computed separately. 
Table 4 
Influence of fish consumption on the triglyceride lowering efficacy of fish oils 
Fish consumption n Triglycerides 
(No. meals/week) 
Baseline Week 8 % P 
1 st tertile (l-4) 7 344Z61 222222 L 35.5 0.0132 
2nd tertile (5-6) 6 6602356 335t134 ‘a 49.2 
3rd tertile (7-9) 6 325252 3882112 719.4 - 
lst+2nd tertiles 13 502-c 179 279267 L44.4 0.0622 
Triglyceride lowering effect of fish oils in subgroups of patients, divided into textiles according to the number of meals with fish consumed 
per week. 
triglyceridaemia and mixed hyperlipidaemia, nd the the fact that it is rich in w-6 unsaturated fatty acids 
influence of fish consumption on the triglyceride and has some a-linolenic acid, and it may have its 
lowering capacity of fish oils. This was a double- own effects [4-71, although not pronounced. 
blind study in which patients were randomly as- Contrasting results of fish oils on circulating lipids 
signed to receive either fish oil (3.6 g/day of w-3) or have been reported by various authors, particularly 
soya oil for a period of 2 months. The soya oil group concerning the effect of fish oil on total cholesterol, 
was considered as a control group, notwithstanding LDL-C and HDL-C [g]. These discrepancies may be 
mg/dl 
baseline week 4 week 8 
FISH 
(No. meals/week) 
Fig. 1. The triglyceride (TG) lowering effect of fish oils in subgroups of patients, divided into tertiles according to the number of meals with 
fish consumed per week. 
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explained by a small effect of this compound on 
these parameters, by insufficient sample size, by the 
variability of doses and formulations of w-3 fatty 
acids administered [8], and by the dietary fat intake 
[91. 
Unexpectedly, and without decreasing HDL, (data 
not shown) and HDL-C, both soya oil and fish oils 
decreased apoA-I (Table 2), although we cannot 
exclude an interassay variation. ApoBlOO did not 
change either with soya oil or with fish oils. Others 
did not find any significant influence of fish oils on 
serum apoA-I or apoBlO0 levels [2,10-141, nor any 
effect of soya oil on apoA-I levels [5,6], the HDL-C 
reducing effect of polyunsaturated fatty acids being 
well-known, though. Shepherd et al. [15] reported a 
26% decrease in apoA-I synthesis in subjects con- 
suming a diet that provided 40% of calories from fat 
with a P/S ratio of 4.0. 
The predominant effect of long chain w-3 fatty 
acids on lipid and lipoprotein metabolism in cell 
culture systems, animals or humans is to reduce 
triglyceride concentrations [8,16], by decreasing the 
activity of acyl-CoA: 1,2-diacylglycerol acyl transfer- 
ase, the last enzyme in triglyceride synthesis [ 161. 
The average reduction of triglycerides is dose related 
[9,17], the minimal effective dose of w-3 fatty acids 
being about 1 g daily and a plateau being reached at 
between 5 and 10 g [17]. 
By showing a reduction in triglyceride levels with 
no change in total and HDL-C, and a slight increase 
in LDL-C and glucose, as we have already shown 
[18], our results are in agreement with many of the 
studies so far published [8,16,19-211. This latter 
effect may limit the use of fish oils in diabetic 
patients, although the question as to whether fish oils 
should be given to type II diabetics has not been 
settled, the results of several studies being contradic- 
tory [10,11,19-261. 
The lack of a statistically significant change on 
triglycerides with fish oils could be partially due to 
the fact that the Portuguese diet is rich in fibre [3], 
which may interfere with fat digestibility and absorp- 
tion [27], affecting fish oils absorption. Moreover, 
epidemiological data suggest that cardiovascular 
protection is obtained with a fish consumption as low 
as one or two meals per week [28], and that 
maximum benefits on lipid profile of the general 
population are obtained with three or four meals per 
week [29]. As our patients are high fish consumers, 
this may have decreased the lowering effect of fish 
oils. 
Interestingly, our results show that moderate doses 
of fish oils can further improve the lipid profile of 
the average fish consumers, but high consumers of 
fish derived no benefit on their triglycerides from the 
administered ose of fish oils. Accordingly, in our 
patients there was an inverse relationship between 
fish consumption and fish oils effect (p=-0.352, 
P=O.O735, IZ= 19), and the percentage of triglyceride 
lowering with fish oils increased (from 27.8% to 
44.4%), reaching borderline significance, if we ex- 
cluded patients consuming one or more meals with 
fish per day (Table 4). The group of patients 
consuming one to four fish meals per week sig- 
nificantly lowered triglyceride levels with fish oils 
owing to a not too high standard error of the mean. 
The highest fish consumers suffered a moderate, 
although not statistically significant, increase in 
triglyceride levels, precisely the same percentage 
seen with soya oil, perhaps a consequence of an 
extra charge of the diet with fatty acids. These data 
clearly demonstrate that fish consumption is an 
important modulator of fish oil efficacy. 
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